361 CAPITAL LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 263 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2020. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
361 CAPITAL LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2020$1,074,000
-13.2%
18,555
-19.2%
0.49%
+42.3%
Q4 2019$1,238,000
+2.6%
22,956
-3.9%
0.34%
+63.3%
Q1 2019$1,207,000
-21.8%
23,895
-21.8%
0.21%
-40.0%
Q2 2018$1,543,000
-0.8%
30,556
+3.4%
0.35%
-9.1%
Q1 2018$1,556,000
-36.4%
29,547
-43.9%
0.38%
-36.5%
Q4 2017$2,447,000
+1105.4%
52,662
+948.0%
0.61%
+1453.8%
Q3 2017$203,0005,0250.04%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 119,994$12,399,0006.09%
Hillcrest Asset Management LLC 161,826$16,721,0002.96%
SNYDER CAPITAL MANAGEMENT L P 664,662$68,680,0002.94%
Copper Rock Capital Partners, LLC 83,374$8,615,0002.91%
RICE HALL JAMES & ASSOCIATES, LLC 623,132$64,388,0002.60%
Tygh Capital Management, Inc. 130,526$13,487,0002.56%
PALISADE CAPITAL MANAGEMENT, LP 428,875$44,316,0001.31%
BECK CAPITAL MANAGEMENT, LLC 22,067$2,280,0001.29%
EARNEST PARTNERS LLC 1,394,794$144,124,0001.24%
DC Investments Management, LLC 10,945$1,131,0001.24%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders